We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXP icon
676
Eagle Materials
EXP
$6.6B
– –
-32,560
Closed -$3.21M
FTI icon
677
TechnipFMC
FTI
$30.6B
– –
-288,921
Closed -$7.64M
IPG
678
DELISTED
Interpublic Group of Companies
IPG
– –
-167,906
Closed -$3.93M
JBHT icon
679
JB Hunt Transport Services
JBHT
$27.1B
– –
-3,012
Closed -$292K
KEYS icon
680
Keysight
KEYS
$54.5B
– –
-58,980
Closed -$2.16M
LYV icon
681
Live Nation Entertainment
LYV
$41.2B
– –
-128,559
Closed -$3.42M
MGNX icon
682
MacroGenics
MGNX
$235M
– –
-60,000
Closed -$1.23M
NAVI icon
683
Navient
NAVI
$774M
– –
-275,319
Closed -$4.52M
OLED icon
684
Universal Display
OLED
$3.71B
– –
-24,528
Closed -$1.38M
TSN icon
685
Tyson Foods
TSN
$20.2B
– –
-22,894
Closed -$1.41M
VIPS icon
686
Vipshop
VIPS
$6.84B
– –
-297,000
Closed -$3.27M
WAB icon
687
Wabtec
WAB
$51.1B
– –
-2,759
Closed -$229K
WRB icon
688
W.R. Berkley
WRB
$28B
– –
-41,978
Closed -$827K
YUMC icon
689
Yum China
YUMC
$14.9B
– –
-8,209
Closed -$214K
LUMO
690
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-2,778
Closed -$257K
TRVN
691
DELISTED
Trevena, Inc.
TRVN
– –
-256
Closed -$941K
INFI
692
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-80,000
Closed -$108K
PBCT
693
DELISTED
People's United Financial Inc
PBCT
– –
-10,163
Closed -$197K
NUAN
694
DELISTED
Nuance Communications, Inc.
NUAN
– –
-94,178
Closed -$1.22M
STML
695
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-244,000
Closed -$2.61M
ZAYO
696
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-30,730
Closed -$1.01M
BEAV
697
DELISTED
B/E Aerospace Inc
BEAV
– –
-125,324
Closed -$7.54M
SE
698
DELISTED
Spectra Energy Corp Wi
SE
– –
-152,201
Closed -$6.25M
ARIA
699
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-210,000
Closed -$2.61M
STJ
700
DELISTED
St Jude Medical
STJ
– –
-16,168
Closed -$1.3M
25 26 27
28
29

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.